⌘K

Login Start Free

Home/Filings/4/0001127602-24-020203

4//SEC Filing

WADE JEFFREY L 4

Accession 0001127602-24-020203

CIK 0001062822other

View on SEC.gov Company Profile

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 5:27 PM ET

Size

5.4 KB

Accession

0001127602-24-020203

Insider Transaction Report

Form 4

Period: 2024-07-08

LEXICON PHARMACEUTICALS, INC.LXRX

EVP, Gen. Counsel

Transactions

Award
Stock Option (Right to Buy)
2024-07-08+307,000→ 307,000 total
Exercise: $1.67Exp: 2034-07-08→ Common Stock (307,000 underlying)

Footnotes (1)

[F1]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

LEXICON PHARMACEUTICALS, INC.

CIK 0001062822

Entity typeother

Related Parties

1

filerCIK 0001225767

Filing Metadata

Form type: 4
Filed: Jul 7, 8:00 PM ET
Accepted: Jul 8, 5:27 PM ET
Size: 5.4 KB

View on SEC.gov